Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice

Immunobiology

Volumn 217, Issue 8, 2012, Pages 823-830

  Kamali, Ali N ^a   Marín García, Patricia ^a,b   Azcárate, Isabel G ^a   Diez, Amalia ^a   Puyet, Antonio ^a   Bautista, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD EUROPEA DE MADRID   (Spain)

Author keywords

Antigens; Heat shock protein; Immunoglobulins; Malaria; Mass spectrometry; Plasmepsin; Protein disulfide isomerase; Translation initiation factor 3

Indexed keywords

HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN G ANTIBODY; INITIATION FACTOR 3; PARASITE ANTIGEN; PROTEIN DISULFIDE ISOMERASE;

AFFINITY CHROMATOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEOMICS;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ASPARTIC ACID ENDOPEPTIDASES; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; DISEASE RESISTANCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EUKARYOTIC INITIATION FACTOR-3; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED ICR; PLASMODIUM YOELII; PROTEIN DISULFIDE-ISOMERASES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84862490951     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2012.05.002     Document Type: Article

References (60)

1. Alaro J.R., Lynch M.M., Burns J.M. Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection. Vaccine 2010, 28:6876-6884.
2. Baruch D.I., Gamain B., Barnwell J.W., Sullivan J.S., Stowers A., Galland G.G., Miller L.H., Collins W.E. Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:3860-3865.
3. Behr C., Sarthou J.L., Rogier C., Trape J.F., Dat M.H., Michel J.C., Aribot G., Dieye A., et al. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum. J. Immunol. 1992, 149:3321-3330.
4. Bergmann-Leitner E.S., Mease R.M., Duncan E.H., Khan F., Waitumbi J., Angov E. Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies. Malar. J. 2008, 7:129.
5. Betney R., de Silva E., Krishnan J., Stansfield I. Autoregulatory systems controlling translation factor expression: thermostat-like control of translational accuracy. RNA 2010, 16:655-663.
6. Biswas S., Sharma Y.D. Lack of correlation between red cell invasion by merozoites and anti-heat shock protein-70 antibody levels in malaria patients' sera. Int. J. Parasitol. 1991, 21:213-217.
7. Blackman M.J., Holder A.A. Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol. 1992, 50:307-315.
8. Borden P., Kabat E.A. An immunochemical analysis of precipitating and non-precipitating idiotype-anti-idiotype reactions. Mol. Immunol. 1990, 27:487-494.
9. Coombs G.H., Goldberg D.E., Klemba M., Berry C., Kay J., Mottram J.C. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol. 2001, 17:532-537.
10. Crabb B.S., de Koning-Ward T.F., Gilson P.R. Protein export in Plasmodium parasites: from the endoplasmic reticulum to the vacuolar export machine. Int. J. Parasitol. 2010, 40:509-513.
11. Crompton P.D., Kayala M.A., Traore B., Kayentao K., Ongoiba A., Weiss G.E., Molina D.M., Burk C.R., et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:6958-6963.
12. Daly T.M., Long C.A. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J. Immunol. 1995, 155:236-243.
13. Dame J.B., Yowell C.A., Omara-Opyene L., Carlton J.M., Cooper R.A., Li T. Plasmepsin 4, the food vacuole aspartic proteinase found in all Plasmodium spp. infecting man. Mol. Biochem. Parasitol. 2003, 130:1-12.
14. de Koning-Ward T.F., Gilson P.R., Boddey J.A., Rug M., Smith B.J., Papenfuss A.T., Sanders P.R., Lundie R.J., et al. A newly discovered protein export machine in malaria parasites. Nature 2009, 459:945-949.
15. Doolan D.L., Mu Y., Unal B., Sundaresh S., Hirst S., Valdez C., Randall A., Molina D., et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 2008, 8:4680-4694.
16. Dutta S., Lalitha P.V., Ware L.A., Barbosa A., Moch J.K., Vassell M.A., Fileta B.B., Kitov S., et al. Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect. Immun. 2002, 70:3101-3110.
17. Ellis R.D., Sagara I., Doumbo O., Wu Y. Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Hum. Vaccin. 2010, 6:627-634.
18. Fontaine A., Pophillat M., Bourdon S., Villard C., Belghazi M., Fourquet P., Durand C., Lefranc D., et al. Specific antibody responses against membrane proteins of erythrocytes infected by Plasmodium falciparum of individuals briefly exposed to malaria. Malar. J. 2010, 9:276.
19. Friesen J., Silvie O., Putrianti E.D., Hafalla J.C., Matuschewski K., Borrmann S. Natural immunization against malaria: causal prophylaxis with antibiotics. Sci. Transl. Med. 2010, 2:40ra49.
20. Good M.F. A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking. Trends Parasitol. 2011, 27:335-340.
21. Goodman A.L., Draper S.J. Blood-stage malaria vaccines - recent progress and future challenges. Ann. Trop. Med. Parasitol. 2010, 104:189-211.
22. Guevara Patino J.A., Holder A.A., McBride J.S., Blackman M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 1997, 186:1689-1699.
23. Holder A.A., Freeman R.R. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 1981, 294:361-364.
24. John C.C., O'Donnell R.A., Sumba P.O., Moormann A.M., de Koning-Ward T.F., King C.L., Kazura J.W., Crabb B.S. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa. J. Immunol. 2004, 173:666-672.
25. Kaboord B., Perr M. Isolation of Proteins and Protein Complexes by Immunoprecipitation 2008, Humana Press, Totowa, NJ.
26. Kicska G.A., Ting L.M., Schramm V.L., Kim K. Effect of dietary p-aminobenzoic acid on murine Plasmodium yoelii infection. J. Infect. Dis. 2003, 188:1776-1781.
27. Kumar N., Zhao Y., Graves P., Perez Folgar J., Maloy L., Zheng H. Human immune response directed against Plasmodium falciparum heat shock-related proteins. Infect. Immun. 1990, 58:1408-1414.
28. Langhorne J., Quin S.J., Sanni L.A. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem. Immunol. 2002, 80:204-228.
29. Langhorne J., Ndungu F.M., Sponaas A.M., Marsh K. Immunity to malaria: more questions than answers. Nat. Immunol. 2008, 9:725-732.
30. Li C., Seixas E., Langhorne J. Rodent malarias: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite. Med. Microbiol. Immunol. 2001, 189:115-126.
31. Liu J., Gluzman I.Y., Drew M.E., Goldberg D.E. The role of Plasmodium falciparum food vacuole plasmepsins. J. Biol. Chem. 2005, 280:1432-1437.
32. Mahajan B., Noiva R., Yadava A., Zheng H., Majam V., Mohan K.V., Moch J.K., Haynes J.D., et al. Protein disulfide isomerase assisted protein folding in malaria parasites. Int. J. Parasitol. 2006, 36:1037-1048.
33. Mahajan B., Berzofsky J.A., Boykins R.A., Majam V., Zheng H., Chattopadhyay R., de la Vega P., Moch J.K., et al. Multiple antigen peptide vaccines against Plasmodium falciparum malaria. Infect. Immun. 2010, 78:4613-4624.
34. Mendez D., Hernaez M.L., Diez A., Puyet A., Bautista J.M. Combined proteomic approaches for the identification of specific amino acid residues modified by 4-hydroxy-2-nonenal under physiological conditions. J. Proteome Res. 2010, 9:5770-5781.
35. Moneriz C., Marin-Garcia P., Bautista J.M., Diez A., Puyet A. Parasitostatic effect of maslinic acid. II: survival increase and immune protection in lethal Plasmodium yoelii-infected mice. Malar. J. 2011, 10:103.
36. Mouray E., Moutiez M., Girault S., Sergheraert C., Florent I., Grellier P. Biochemical properties and cellular localization of Plasmodium falciparum protein disulfide isomerase. Biochimie 2007, 89:337-346.
37. Neuhoff V., Arold N., Taube D., Ehrhardt W. Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988, 9:255-262.
38. Novo C., Martins T.M., Prata S., Lopes A., Armada A. Gene sequencing, modelling and immunolocalization of the protein disulfide isomerase from Plasmodium chabaudi. Int. J. Biol. Macromol. 2009, 45:399-406.
39. Omara-Opyene A.L., Moura P.A., Sulsona C.R., Bonilla J.A., Yowell C.A., Fujioka H., Fidock D.A., Dame J.B. Genetic disruption of the Plasmodium falciparum digestive vacuole plasmepsins demonstrates their functional redundancy. J. Biol. Chem. 2004, 279:54088-54096.
40. Omodeo-Sale F., Cortelezzi L., Vommaro Z., Scaccabarozzi D., Dondorp A.M. Dysregulation of l-arginine metabolism and bioavailability associated to free plasma heme. Am. J. Physiol. Cell Physiol. 2010, 299:C148-C154.
41. Pritzker L.B., Scatena M., Giachelli C.M. The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. Mol. Biol. Cell. 2004, 15:2834-2841.
42. Qoronfleh M.W., Ren L., Emery D., Perr M., Kaboord B. Use of immunomatrix methods to improve protein-protein interaction detection. J. Biomed. Biotechnol. 2003, 2003:291-298.
43. Ren L., Emery D., Kaboord B., Chang E., Qoronfleh M.W. Improved immunomatrix methods to detect protein:protein interactions. J. Biochem. Biophys. Methods 2003, 57:143-157.
44. Renia L., Mattei D., Goma J., Pied S., Dubois P., Miltgen F., Nussler A., Matile H., et al. A malaria heat-shock-like determinant expressed on the infected hepatocyte surface is the target of antibody-dependent cell-mediated cytotoxic mechanisms by nonparenchymal liver cells. Eur. J. Immunol. 1990, 20:1445-1449.
45. Roestenberg M., McCall M., Hopman J., Wiersma J., Luty A.J., van Gemert G.J., van de Vegte-Bolmer M., van Schaijk B., et al. Protection against a malaria challenge by sporozoite inoculation. N. Engl. J. Med. 2009, 361:468-477.
46. Roestenberg M., Teirlinck A.C., McCall M.B., Teelen K., Makamdop K.N., Wiersma J., Arens T., Beckers P., et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 2011, 377:1770-1776.
47. Roque A.C., Silva C.S., Taipa M.A. Affinity-based methodologies and ligands for antibody purification: advances and perspectives. J. Chromatogr. A 2007, 1160:44-55.
48. + T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666.
49. Shear H.L., Ng C., Zhao Y. Cytokine production in lethal and non-lethal murine malaria. Immunol. Lett. 1990, 25:123-127.
50. Snowden C.J., Leborgne-Castel N., Wootton L.J., Hadlington J.L., Denecke J. In vivo analysis of the lumenal binding protein (BiP) reveals multiple functions of its ATPase domain. Plant J. 2007, 52:987-1000.
51. Spaccapelo R., Janse C.J., Caterbi S., Franke-Fayard B., Bonilla J.A., Syphard L.M., Di Cristina M., Dottorini T., et al. Plasmepsin 4-deficient Plasmodium berghei are virulence attenuated and induce protective immunity against experimental malaria. Am. J. Pathol. 2010, 176:205-217.
52. Struik S.S., Riley E.M. Does malaria suffer from lack of memory?. Immunol. Rev. 2004, 201:268-290.
53. Taylor-Robinson A.W. Regulation of immunity to malaria: valuable lessons learned from murine models. Parasitol. Today 1995, 11:334-342.
54. Taylor D.W., Pacheco E., Evans C.B., Asofsky R. Inbred mice infected with Plasmodium yoelii differ in their antimalarial immunoglobulin isotype response. Parasite Immunol. 1988, 10:33-46.
55. Tolia N.H., Enemark E.J., Sim B.K., Joshua-Tor L. Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum. Cell 2005, 122:183-193.
56. Trieu A., Kayala M.A., Burk C., Molina D.M., Freilich D.A., Richie T.L., Baldi P., Felgner P.L., et al. Sterile protective immunity to malaria is associated with a panel of novel P. falciparum antigens. Mol. Cell. Proteomics 2011, 10. M111 007948.
57. White W.I., Evans C.B., Taylor D.W. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect. Immun. 1991, 59:3547-3554.
58. Yadava A., Ockenhouse C.F. Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Infect. Immun. 2003, 71:4961-4969.
59. Yeo T.W., Lampah D.A., Gitawati R., Tjitra E., Kenangalem E., McNeil Y.R., Darcy C.J., Granger D.L., et al. Impaired nitric oxide bioavailability and l-arginine reversible endothelial dysfunction in adults with falciparum malaria. J. Exp. Med. 2007, 204:2693-2704.
60. Zhang M., Hisaeda H., Sakai T., Ishikawa H., Hao Y.P., Nakano Y., Ito Y., Himeno K. Macrophages expressing heat-shock protein 65 play an essential role in protection of mice infected with Plasmodium yoelii. Immunology 1999, 97:611-615.